ArticleComputational and structural biotechnology journal2025
Ranking pre-trained speech embeddings in Parkinson's disease detection: Does Wav2Vec 2.0 outperform its 1.0 version across speech modes and languages?
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Voice-Based Detection of Parkinson's Disease Using Machine and Deep Learning Approaches: A Systematic Review.Bioengineering (Basel, Switzerland) · 2025Review
- Multi-Channel Spectro-Temporal Representations for Speech-Based Parkinson's Disease Detection.Journal of imaging · 2025Article
- Speech-Based Parkinson's Detection Using Pre-Trained Self-Supervised Automatic Speech Recognition (ASR) Models and Supervised Contrastive Learning.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Speech and language technologies are effective tools for identifying the distinct speech changes associated with Parkinson's disease (PD), enabling earlier and more accurate diagnosis. Models leveraging recent advancements in self-supervised speech pretraining, such as Wav2Vec, have demonstrated superior performance over traditional feature extraction methods. While Wav2Vec 2.0 has been successfully utilized for PD detection, a rigorous quantitative comparison with Wav2Vec 1.0 is needed to comprehensively evaluate its advantages, limitations, and applicability across different speech modes in PD. This study presents a systematic comparison of Wav2Vec 1.0 and Wav2Vec 2.0 embeddings across three multilingual datasets using various classification approaches to classify normal (healthy controls; HC) and PD-affected speech. Additionally, both Wav2Vec 1.0 and 2.0 were benchmarked against traditional baseline features across diverse linguistic contexts, including spontaneous speech, non-spontaneous speech, and isolated vowels. A multicriteria TOPSIS approach was employed to rank feature extraction methods, revealing that Wav2Vec 2.0 excelled across speech modes, with its first transformer layer demonstrating the best performance for classifying read text and monologue, and its feature extractor performing best in vowel-based classification. In contrast, Wav2Vec 1.0, while generally outperformed by Wav2Vec 2.0, still provided a more efficient alternative with competitive performance. Finally, we combined selected layers from both architectures and have demonstrated improved diagnostic accuracy in vowel-based classification. This comparative analysis underscores the strengths of both Wav2Vec architectures and informs their optimal use in PD detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.